Methylene blue photochemical treatment as a reliable SARS-CoV-2 plasma virus inactivation method for blood safety and convalescent plasma therapy for COVID-19

Methylene blue photochemical treatment as a reliable SARS-CoV-2 plasma virus inactivation method for blood safety and convalescent plasma therapy for COVID-19

Abstract Background In 2020, a new coronavirus, SARS-CoV-2, quickly spread worldwide within a few months. Although coronaviruses typically infect the upper or lower respiratory tract, the virus RNA can be detected in plasma. The risk of transmitting coronavirus via transfusion of blood products rema...

Full description

Bibliographic Details
Main Authors: Changzhong Jin, Bin Yu, Jie Zhang, Hao Wu, Xipeng Zhou, Hangping Yao, Fumin Liu, Xiangyun Lu, Linfang Cheng, Miao Jiang, Nanping Wu
Format: Article
Language:English
Published: BMC 2021-04-01
Series:BMC Infectious Diseases
Subjects:
Methylene blue
Photochemical treatment
SARS-CoV-2
Plasma virus inactivation
Blood safety
Convalescent plasma therapy
Online Access:https://doi.org/10.1186/s12879-021-05993-0

Internet

https://doi.org/10.1186/s12879-021-05993-0

Similar Items